Carl Zeiss Meditec (ETR:AFX) Shares Down 3% – What’s Next?

Carl Zeiss Meditec AG (ETR:AFX) traded down 3% during mid-day trading on Friday . The stock traded as low as €27.04 and last traded at €27.34. Approximately 268,173 shares traded hands during mid-day trading, an increase of 184% from the average daily volume of 94,405 shares. The stock had previously closed at €28.20.

Carl Zeiss Meditec Price Performance

The stock has a market cap of $2.59 billion, a P/E ratio of 14.86, a P/E/G ratio of 2.83 and a beta of 1.33. The company’s 50 day moving average price is €27.01 and its 200-day moving average price is €27.78. The company has a quick ratio of 2.47, a current ratio of 2.43 and a debt-to-equity ratio of 29.43.

Carl Zeiss Meditec Company Profile

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data.